Výsledky vyhledávání - "HOST-DIRECTED THERAPIES"

Akademický článek

Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles

Autor: Carmen Palomino-Cano, Esther Moreno, Juan M. Irache, Socorro Espuelas

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

Macrophages play a pivotal role as host cells for Leishmania parasites, displaying a notable functional adaptability ranging from the proinflammatory, leishmanicidal M1 phenotype to the anti-inflammatory, parasite-permissive M2 phenotype. While macro

Externí odkaz: https://doaj.org/article/f6a25dfb8ee44daa8d9c1f83552406dc

Zobrazit plný text záznamu

Akademický článek

Next-generation treatments: Immunotherapy and advanced therapies for COVID-19

Autor: Jenny Andrea Arevalo-Romero, Sandra M. Chingaté-López, Bernardo Armando Camacho, Carlos Javier Alméciga-Díaz, Cesar A. Ramirez-Segura

Publikováno v: Heliyon, Vol 10, Iss 5, Pp e26423- (2024)

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in 2019 following prior outbreaks of coronaviruses like SARS and MERS in recent decades, underscoring their high potential of infectivity in humans

Externí odkaz: https://doaj.org/article/e9ae094f206b4d5c901d4cd4bf563ed6

Zobrazit plný text záznamu

Akademický článek

SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen

Autor: Lilibeth Arias, Kennedy Otwombe, Ziyaad Waja, Nestani Tukvadze, Tamta Korinteli, Tumelo Moloantoa, Kaori L Fonseca, Natasha Pillay, Thabiso Seiphetlo, Dan Ouchi-Vernet, Adrian Siles, Lidia Carabias, Carles Quiñones, Sergo Vashakidze, Neil Martinson, Cristina Vilaplana

Publikováno v: Trials, Vol 24, Iss 1, Pp 1-16 (2023)

Abstract Background The duration and regimen of tuberculosis (TB) treatment is currently based predominantly on whether the M. tuberculosis (Mtb) strain is drug-sensitive (DS) or multidrug-resistant (MDR) with doses adjusted by patients’ weight onl

Externí odkaz: https://doaj.org/article/84f87ca4e04d4ec18d56201863085e5a

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Differential Regulation of TFEB-Induced Autophagy during Mtb Infection and Starvation

Autor: Richa Dwivedi, Piyush Baindara

Publikováno v: Microorganisms, Vol 11, Iss 12, p 2944 (2023)

Through the promotion of phagolysosome formation, autophagy has emerged as a crucial mechanism to eradicate intracellular Mycobacterium tuberculosis (Mtb). A cell-autonomous host defense mechanism called lysosome biogenesis and autophagy transports c

Externí odkaz: https://doaj.org/article/2ede15ad5c14475091e1e48dcb4bded5

Zobrazit plný text záznamu

Akademický článek

Validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol [version 1; peer review: 2 approved]

Autor: Jessica More, Denelle Moodley, Mohlopheni J Marakalala, Kerishka Rajkumar-Bhugeloo, Thabo Mpotje

Publikováno v: Wellcome Open Research, Vol 8 (2023)

The presence of the Tuberculosis (TB) disease-causing pathogen, Mycobacterium Tuberculosis (Mtb), induces the development of a pathological feature termed granuloma, which the host uses to contain the bacteria. However, the granuloma may dissociate r

Externí odkaz: https://doaj.org/article/042e9a9a84a747abb9b45b9a0c0d4b5b

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Modulation of Cystatin F in Human Macrophages Impacts Cathepsin-Driven Killing of Multidrug-Resistant Mycobacterium tuberculosis

Autor: Manoj Mandal, David Pires, Maria João Catalão, José Miguel Azevedo-Pereira, Elsa Anes

Publikováno v: Microorganisms, Vol 11, Iss 7, p 1861 (2023)

Tuberculosis (TB) treatment relies primarily on 70-year-old drugs, and prophylaxis suffers from the lack of an effective vaccine. Among the 10 million people exhibiting disease symptoms yearly, 450,000 have multidrug or extensively drug-resistant (MD

Externí odkaz: https://doaj.org/article/2b6bdd2aff4f4531a9716597f03217b6

Zobrazit plný text záznamu

Akademický článek

Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients

Autor: Vinzeigh N. Leukes, Stephanus T. Malherbe, Andriette Hiemstra, Leigh A. Kotze, Kelly Roos, Alana Keyser, Dalene De Swardt, Andrea Gutschmidt, Gerhard Walzl, Nelita du Plessis

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

Successful TB treatment is hampered by increasing resistance to the two most effective first-line anti-TB drugs, namely isoniazid and rifampicin, thus innovative therapies focused on host processes, termed host-directed therapies (HDTs), are promisin

Externí odkaz: https://doaj.org/article/c412de5fcccf443887d1b48438fa8307

Zobrazit plný text záznamu

Akademický článek

Viral-Host Dependency Factors as Therapeutic Targets to Overcome Antiviral Drug-Resistance: A Focus on Innate Immune Modulation

Autor: Roger Badia, Edurne Garcia-Vidal, Ester Ballana

Publikováno v: Frontiers in Virology, Vol 2 (2022)

The development of antiviral drugs, has provided enormous achievements in our recent history in the fight against viral infections. To date, most of the approved antiviral drugs target virus-encoded proteins to achieve direct antiviral activity. None

Externí odkaz: https://doaj.org/article/b1c94ac654a34db2957d01737da61dc8

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání